Guest: Harry Paul Erba, MD, PhD Although survival among younger patients with acute myeloid leukemia (AML) has improved over the past decade, older patients continue to have a poor prognosis. And since age and frailty are the primary predictors of outcome among patients with AML, Dr. Harry Erba shares how the treatment of older patients with AML may be changing. BCL2-US-00027-MCVersion 2.0, Approved November 2020

Spotlight On

Changing Our View of Acute Myeloid Leukemia in Older Adults

Guest: Matthew S. Davids, MD, MMSc In addition to complete response, some clinical trials are also using minimal residual disease (MRD) to measure depth of response in chronic lymphocytic leukemia. But how exactly is MRD being defined and discussed in CLL? Here to answer that question and more is Dr. Matthew Davids, Associate Professor of Medicine at Harvard Medical School and Associate Director of the Center for Chronic Lymphocytic Leukemia at Dana-Farber Cancer Institute in Boston, Massachusetts. ABBV-US-00196-MCVersion 1.0, Approved August 2020

Measuring Depth of Remission in Chronic Lymphocytic Leukemia

Guest: MeiLan K. Han, MD, MS For patients with COPD, exacerbations can have an irreversible and sustained impact on their daily life.3,4 Additionally, exacerbations are often underreported.5 That’s why Dr. MeiLan Han is here to walk us through the importance of exacerbation recognition and prevention, the health and life burdens of exacerbations, and patient-physician communication gaps. References: Halpin DMG, Decramer M, Celli BR, et al. Effect of a single exacerbation on decline in lung function in COPD. Respir Med. 2017;128:85-91. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091-1097. O’Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155(1):109-115. Roche N. Activity limitation: a major consequence of dyspnoea in COPD. Eur Respir Rev. 2009;18(112):54-57. Leidy NK, Murray LT, Jones P, Sethi S. Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(3):316-325. ©2020 AstraZeneca. All rights reserved. US-42455 Last Updated 8/20

Unleash the Truth About COPD

Host: Matt Birnholz, MD Guest: Sanjay Chabra, MD As stated by Dr. Sanjay Chabra, "About 19 percent of the population lives with chronic back pain, but what about when it’s inflammatory—not mechanical—back pain?" Join Dr. Matt Birnholz as he sits down with Dr. Chabra at the 2019 American College of Rheumatology annual meeting in Atlanta, Georgia, to share strategies that can help us shorten the delay in the diagnosis of ankylosing spondylitis that often occurs within and around rheumatology practices. PP-IX-US-3710 04/2020 ©Lilly USA, LLC 2020. All rights reserved.

Exploring the Underdiagnosis of AS Within & Around Rheumatology Practices

Host: Matt Birnholz, MD Guest: Smitha Reddy, MD Join Dr. Matt Birnholz as he sits down with Dr. Smitha Reddy at the annual rheumatology meeting in Atlanta, Georgia to explore how an anti-inflammatory diet could have an impact on a rheumatoid arthritis patient's lifestyle. PP-BA-US-1149 2/2020 ©Lilly USA, LLC 2020. All rights reserved.

Dietary Understandings & Updates for Rheumatoid Arthritis Patients

Host: Paul Doghramji, MD Guest: David H. Peyton, Ph.D. The vaping epidemic is becoming more and more concerning, but could new research prompt people to quit? To find out, Dr. Paul Doghramji speaks with Dr. David Peyton about his recent study that challenges the claim that vaping devices take less of a toll on our health than tobacco smoking.

The Harsh Truth Behind the Vaping Epidemic

Host: Jennifer Caudle, DO Guest: Sergio Schwartzman, MD Since primary care physicians are on the frontlines of healthcare, they play an important role in not only diagnosing and managing patients with spondyloarthritis, but also referring those patients to rheumatologists when appropriate. Here to walk through what primary care physicians should consider is rheumatologist Dr. Sergio Schwartzman. This activity is intended for United States and Puerto Rico health care professionals only.

Managing Spondyloarthritis: The Role of Primary Care Physicians

Host: Sergio Schwartzman, MD Guest: Michael Payette, MD, MBA, FAAD Patients with spondyloarthritis can experience a wide range of dermatologic manifestations ranging from psoriasis to erythema nodosum, making collaborative care between rheumatologists and dermatologists essential. Here to talk about how rheumatologists like Dr. Sergio Schwartzman can manage and refer patients with spondyloarthritis to dermatologists—and vice versa—is Dr. Michael Payette, co-founder of Central Connecticut Dermatology. This activity is intended for United States and Puerto Rico health care professionals only.

A Dermatologic Perspective on Spondyloarthritis Above & Beneath the Skin’s Surface

Host: Sergio Schwartzman, MD Guest: Stephen Hanauer, MD Even though there’s a known relationship between inflammatory bowel disease (IBD) and spondyloarthritis, not all arthropathies associated with IBD signal spondyloarthritis. So how can gastroenterologists and rheumatologists work together to identify and manage those that are? That’s what rheumatologist Dr. Sergio Schwartzman breaks down with Dr. Stephen Hanauer, Medical Director of the Digestive Health Center at Northwestern University Feinberg School of Medicine. This activity is intended for United States and Puerto Rico health care professionals only.

The Link Between Spondyloarthritis & IBD: A Gastroenterological Perspective

Host: Sergio Schwartzman, MD Guest: Jennifer Thorne, MD, PhD Did you know that more than 20 percent of patients with spondyloarthritis experience at least one episode of uveitis? Or that nearly half of patients with uveitis may also have undiagnosed spondyloarthritis? That’s why co-managed care is so important for these patients, as rheumatologist Dr. Sergio Schwartzman and ophthalmologist Dr. Jennifer Thorne explain. This activity is intended for United States and Puerto Rico health care professionals only.

Looking at Spondyloarthritis from an Ophthalmologic Perspective

Host: Matt Birnholz, MD Guest: Michael McKee, MD, FRCS(C) Diagnosing and treating nonunion fractures comes with its set of challenges. Fortunately, Dr. Michael McKee is here to share his expertise and recommendations for success to benefit your patients with nonunion fractures.

Overcoming Obstacles in Treating Nonunion Fractures

Host: Matt Birnholz, MD Guest: Michael R Redler, MD Guest: Ryan Riggs, MD Osteoarthritis is a progressive joint disease that affects millions worldwide, and with incidence rates continuing to climb due to a longer-living population and an increase in obesity, staying up to date on the latest treatment approaches is essential. Join Drs. Michael Redler and Ryan Riggs as they discuss the current treatment landscape for osteoarthritis and what's on the horizon for this growing problem. 

Osteoarthritis: Not Just a Wear-and-Tear Problem

This unique series features the latest developments in medicine, science, and technology produced in conjunction with our sponsors, who are dedicated to bringing healthcare providers lively discussions with experts from around the country. Tune in each week to hear the latest podcasts from ReachMD's "Spotlight On" series.

hubhopper

Spotlight On

hubhopper